BullFrog AI Holdings (BFRGW) EBT Growth (1y) (2023 - 2026)
Powered by 
Analysis
BullFrog AI Holdings (BFRGW) EBT Growth (1y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 210.86 Bn | 196.87 Bn | 7.24 Bn | 76.53% |
| 2 | Gilead Sciences | 181.23 Bn | 178.05 Bn | 6.22 Bn | -522.15% |
| 3 | Vertex Pharmaceuticals | 132.14 Bn | 124.29 Bn | 2.84 Bn | 8.48% |
| 4 | Regeneron Pharmaceuticals | 82.88 Bn | 74.88 Bn | 3.93 Bn | 0.60% |
| 5 | Argenx Se | 61.72 Bn | 56.54 Bn | 1.37 Bn | 88.92% |
| 6 | Moderna | 54.82 Bn | 49.68 Bn | 52.00 Mn | 6.23% |
| 7 | Alnylam Pharmaceuticals | 34.09 Bn | 30.79 Bn | 992.69 Mn | 530.43% |
| 8 | Biogen | 31.28 Bn | 29.99 Bn | 1.96 Bn | -82.20% |
| 9 | Roivant Sciences | 30.40 Bn | 30.40 Bn | 1.16 Mn | - |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 | 5.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.33% |
| Dec 31, 2025 | 15.33% |
| Sep 30, 2025 | 13.90% |
| Jun 30, 2025 | 14.27% |
| Mar 31, 2025 | -8.08% |
| Dec 31, 2024 | -32.35% |
| Sep 30, 2024 | -39.32% |
| Jun 30, 2024 | -9.18% |
| Mar 31, 2024 | -54.46% |
| Dec 31, 2023 | -92.37% |
| Sep 30, 2023 | -71.29% |
| Jun 30, 2023 | -99.47% |
| Mar 31, 2023 | -117.49% |